Cargando…

Novel drugs in the management of difficult-to-treat hepatitis C genotypes

BACKGROUND: Hepatitis C virus (HCV) infection is the most common chronic bloodborne infection in the United States, with approximately 3.2 million Americans being chronically infected. Rates of HCV-related end-stage liver disease and its associated morbidity and mortality have yet to peak, so there...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cartwright, Emily J, Miller, Lesley
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3953740/ https://www.ncbi.nlm.nih.gov/pubmed/24696624 http://dx.doi.org/10.2147/HMER.S48545

Ejemplares similares

Managing chronic hepatitis C in the difficult-to-treat patient
por: Kemmer, Nyingi, et al.
Publicado: (2007)

Cannabinoids in the management of difficult to treat pain
por: Russo, Ethan B
Publicado: (2008)

Efficacy and safety of telaprevir, a new protease inhibitor, for difficult-to-treat patients with genotype 1 chronic hepatitis C
por: Hayashi, N, et al.
Publicado: (2012)

Using vibration controlled transient elastography and FIB-4 to assess liver cirrhosis in a hepatitis C virus infected population
por: Saleem, Nabil, et al.
Publicado: (2021)

Management of difficult-to-treat asthma in adolescence and young adults
por: Mansur, Adel H., et al.
Publicado: (2023)

Management of difficult-to-treat patients with ulcerative colitis: focus on adalimumab
por: Armuzzi, Alessandro, et al.
Publicado: (2013)

Management algorithm for genotype 1 hepatitis C virus
por: Kim, Arthur Y.
Publicado: (2013)

Patients with Haemoglobinopathies and Chronic Hepatitis C: A Real Difficult to Treat Population in 2016?
por: Zachou, Kalliopi, et al.
Publicado: (2017)

Are There Still Difficult-to-Treat Patients with Chronic Hepatitis C in the Era of Direct-Acting Antivirals?
por: Pabjan, Paweł, et al.
Publicado: (2022)

Critical appraisal of pralatrexate in the management of difficult-to-treat peripheral T cell lymphoma
por: Casanova, M, et al.
Publicado: (2011)

Management of Hepatitis C Genotype 4 in the Liver Transplant Setting
por: Al-hamoudi, Waleed K.
Publicado: (2016)

Adenomyosis: Difficult to Diagnose, and Difficult to Treat
por: Wood, C.
Publicado: (2001)

Difficult-to-treat asthma, is it really difficult?
por: Al-Hajjaj, Mohamed S.
Publicado: (2011)

A model for the management of difficult to treat depression
por: Mcallister-Williams, H.
Publicado: (2021)

Psoriasis Management Challenges Regarding Difficult-to-Treat Areas: Therapeutic Decision and Effectiveness
por: Nicolescu, Alin Codrut, et al.
Publicado: (2022)

Difficult-to-Treat Pathogens: A Review on the Management of Multidrug-Resistant Staphylococcus epidermidis
por: Siciliano, Valentina, et al.
Publicado: (2023)

Difficult medical management
por: Bell, P M
Publicado: (1991)

Taking a holistic approach to managing difficult stress fractures
por: Miller, Timothy L., et al.
Publicado: (2016)

Difficult-To-Treat Depression. Scoping Review
por: Paganin, Walter, et al.
Publicado: (2023)

Abatacept in difficult-to-treat juvenile idiopathic arthritis
por: Kuemmerle-Deschner, Jasmin B, et al.
Publicado: (2008)

Cardiovascular Risk Management and Hepatitis C: Combining Drugs
por: Smolders, Elise J., et al.
Publicado: (2018)

Hepatitis C Virus: Viral Quasispecies and Genotypes
por: Tsukiyama-Kohara, Kyoko, et al.
Publicado: (2017)

Clinical review: Management of difficult airways
por: Langeron, Olivier, et al.
Publicado: (2006)

Management of comorbidities in difficult and severe asthma
por: Khan, Jehangir, et al.
Publicado: (2023)

Human fusariosis: An emerging infection that is difficult to treat
por: Batista, Bruna Gerardon, et al.
Publicado: (2020)

Difficult-to-treat-pediatric Crohn’s disease: focus on adalimumab
por: Zeisler, Bella, et al.
Publicado: (2015)

Role of Antifungal Combinations in Difficult to Treat Candida Infections
por: Vitale, Roxana G.
Publicado: (2021)

EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis
por: Nagy, György, et al.
Publicado: (2022)

Hepatitis C Genotypes Distribution in Intravenous Drug Users in Tehran
por: Alavian, Seyed Moayed
Publicado: (2015)

Diagnostic issues in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis
por: Roodenrijs, Nadia M T, et al.
Publicado: (2021)

Managing difficult polyps: techniques and pitfalls
por: Tholoor, Shareef, et al.
Publicado: (2013)

Core as a Novel Viral Target for Hepatitis C Drugs
por: Strosberg, Arthur Donny, et al.
Publicado: (2010)

Graves′ orbitopathy: Management of difficult cases
por: Wiersinga, Wilmar M.
Publicado: (2012)

Inhibitors in haemophilia A and B: Management of bleeds, inhibitor eradication and strategies for difficult‐to‐treat patients
por: Ljung, Rolf, et al.
Publicado: (2018)

Clinical research challenges posed by difficult-to-treat depression
por: Rush, A. John, et al.
Publicado: (2022)

Treatment options for refractory and difficult to treat seizures: focus on vigabatrin
por: Tolman, Justin A, et al.
Publicado: (2011)

Pharmacotherapeutic and Non-Pharmacological Options for Refractory and Difficult-to-Treat Seizures
por: Mitchell, James W., et al.
Publicado: (2012)

Highlighted Advances in Therapies for Difficult-To-Treat Brain Tumours Such as Glioblastoma
por: Cruz, Nuno, et al.
Publicado: (2023)

Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group
por: Than, Nwe Ni, et al.
Publicado: (2019)

Multicellular Modelling of Difficult-to-Treat Gastrointestinal Cancers: Current Possibilities and Challenges
por: Hakuno, Sarah K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7rj9kivcvsen6c7fs0ifq7ujdv